The tumor microenvironment (TME) is the seat of multiple cell interactions, including tumor cells, immune cells, stromal cells, and others. The identification of the markers expressed, and their spatial distribution can help not only to establish a prognosis of the disease, but also to direct therapeutic selection.
In this presentation, Mr. Pedro Espinosa Gonzalez presents how the HALO® and HALO AI platform can be used to analyze images of immuno-oncology panels encompassing a highly multiplexed biomarker panel from the COMET™ platform.
